Ixekizumab Provides Sustained Improvement In Signs And Symptoms In Patients With Active Psoriatic Arthritis: Two Year Results From A Phase 3 Trial

Helliwell, P, Lespessailles, E, Shuler, CL et al. (4 more authors) (2018) Ixekizumab Provides Sustained Improvement In Signs And Symptoms In Patients With Active Psoriatic Arthritis: Two Year Results From A Phase 3 Trial. In: 20th PANLAR Meeting, 07-10 Apr 2018, Buenos Aires, Argentina.

Metadata

Authors/Creators:
  • Helliwell, P
  • Lespessailles, E
  • Shuler, CL
  • Mallbris, L
  • Erickson, J
  • Fleischmann, R
  • Moyano, S
Dates:
  • Published: April 2018
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 29 Sep 2020 10:29
Last Modified: 29 Sep 2020 10:29
Status: Published
Identification Number: https://doi.org/10.1097/RHU.0000000000000802
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)